Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Datang Pharmaceutical Group is a comprehensive pharmaceutical enterprise based in Xi'an, China, specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. Established in 1992, the company operates multiple GMP-certified production lines and maintains a diverse portfolio of over 100 products across various dosage forms, including tablets, capsules, and granules. Its core therapeutic focus areas include cardiovascular health, respiratory conditions, pediatrics, and hepatology. The company is well-known for integrating modern pharmaceutical technology with traditional herbal formulations to serve the domestic Chinese healthcare market. Key products include Fufang Danshen tablets for heart health and various pediatric cough and asthma treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Datang Pharmaceutical Group.